High Vista Strategies LLC Vertex Pharmaceuticals Inc Transaction History

High Vista Strategies LLC

  • $255 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
SELL
$234.96 - $292.55 $881,569 - $1.1 Million
-3,752 Closed
0 $0
Q1 2022

May 16, 2022
SELL
$221.42 - $260.97 $306,223 - $360,921
-1,383 Reduced 26.93%
3,752 $979,000
Q4 2021

Feb 14, 2022
BUY
$177.01 - $223.45 $908,946 - $1.15 Million
5,135 New
5,135 $1.13 Million

Others Institutions Holding VRTX

# of Institutions
1,723
Shares Held
222M
Call Options Held
1.58M
Put Options Held
1.36M
View Full List

About VERTEX PHARMACEUTICALS INC

VRTX Quotes by TradingView
  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $116B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track High Vista Strategies LLC Portfolio

Follow High Vista Strategies LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of High Vista Strategies LLC, based on Form 13F filings with the SEC.

News

Stay updated on High Vista Strategies LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email